Gentuity has announced an agreement with GE HealthCare to collaborate on commercial activities. The collaboration is intended to enhance the availability, adoption, and functionality of highly complementary imaging solutions for interventional cardiology, the companies have announced in a press release.
As part of the agreement, Gentuity and GE HealthCare aim to jointly pursue co-marketing initiatives and technical integration of their respective technologies. GE HealthCare also plans to explore opportunities to expand access to Gentuity’s innovative products through its own distribution network in the USA.
These products include high-frequency optical coherence tomography imaging system, and the Vis-Rx prime micro-imaging catheter, designed for comprehensive vessel imaging before and after percutaneous coronary intervention (PCI) procedures.
“We are thrilled at the opportunity to expand our relationship with GE HealthCare and look forward to bringing our advanced imaging solutions to a broader range of healthcare providers,” said Desmond Adler, president of Gentuity. “Our industry best serves our physicians and patients when we thoughtfully combine complementary technologies in a way that amplifies their individual impact, and we see this collaboration as an important enabling step in that direction.”
“At GE HealthCare, we strive to tell the story of the heart through technologies that help diagnose, treat and monitor cardiovascular conditions,” said Jyoti Gera, chief executive officer, CardioVascular and Interventional Solutions at GE HealthCare. “This joint initiative with Gentuity supports this mission and reflects our shared commitment to delivering high-quality medical devices that that enhance patient outcomes and quality of life.”
